|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of deferred financing costs | |||||
| Accretion of below- and amortization of above-market lease liabilities and assets, net | |||||
| Equity-based compensation | |||||
| Common stock issued to the Advisor in connection with Advisor related fees | |||||
| Common stock issued to directors in lieu of cash for board fees | |||||
| (Gain)/loss on dispositions of real estate | |||||
| Impairment of real estate investments | |||||
| Tenant Improvement - Terminations | |||||
| Changes in assets and liabilities: | |||||
| Straight-line rent receivable | |||||
| Straight-line rent payable | |||||
| Prepaid expenses, other assets and deferred costs | |||||
| Accounts payable, accrued expenses and other liabilities | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Net proceeds from sale of real estate investments | |||||
| Reduction of cash from derecognition of assets | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from notes payable to related parties | |||||
| Payment of mortgage note payable | |||||
| Related Party | |||||
| Nonrelated Party | |||||
| Total payment of mortgage note payable | |||||
| Proceeds from issuance of common stock to affiliates of the advisor, net | |||||
| Proceeds from issuance of common stock, net | |||||
| Proceeds from Rights Offering, net (see Note 9) | |||||
| Dividends paid on common stock | |||||
| Redemption of fractional shares of common stock and restricted shares | |||||
| Distributions to non-controlling interest holders | |||||
| Common stock shares withheld upon vesting of restricted shares | |||||
| Repurchases of common stock | |||||
| Net cash provided by (used in) financing activities | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Supplemental Disclosures: | |||||
| Cash paid for interest | |||||
| Non-Cash Investing and Financing Activities: | |||||
| Common stock issued to directors in lieu of cash for board fees | |||||
| Common stock issued to the Advisor in connection with management fees (see Note 9) | |||||
| Net change in accrued capital expenditures for the period | |||||
| Prepaid common stock issuance costs related to 2021 common stock issuances | |||||
| Contract asset | |||||
| Debt associated with property in receivership | |||||
| Accrued interest associated with property in receivership | |||||
| Derecognition of property in receivership | |||||
Loading...